Publicacións nas que colabora con Moises Rodríguez Mañero (23)

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  3. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

2022

  1. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  2. Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 372-379

  3. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 559-567

2017

  1. Marcapasos transcatéter sin cables Micra. Resultados del implante y seguimiento a medio plazo en un centro

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 275-281

  2. Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure

    International Journal of Cardiology, Vol. 230, pp. 108-114

2016

  1. Comparación entre tres sistemas de puntuación de hemorragia en pacientes con fibrilación auricular no valvular. ¿Qué puede ofrecer la nueva puntuación ORBIT?

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1112-1114

  2. Evaluación comparativa de cuatro puntuaciones de riesgo para predecir la mortalidad de pacientes con desfibrilador automático implantable en prevención primaria

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1033-1041

  3. Prevención primaria de muerte súbita en pacientes con miocardiopatía valvular

    Revista Espanola de Cardiologia, Vol. 69, Núm. 3, pp. 272-278

  4. Risk of pacemaker implantation after uneventful successful cavotricuspid isthmus radiofrequency ablation in patients with common atrial flutter

    International Journal of Cardiology, Vol. 202, pp. 285-288

2015

  1. Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses

    International Journal of Cardiology, Vol. 195, pp. 188-194

  2. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 15, Núm. 1

  3. Evaluation of SAMe-TT<inf>2</inf>R<inf>2</inf> risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists

    Europace, Vol. 17, Núm. 5, pp. 711-717

  4. Is safe to discontinue anticoagulation after successful ablation of atrial flutter?

    International Journal of Cardiology, Vol. 201, pp. 631-632

  5. Long-term outcome prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter

    International Journal of Cardiology, Vol. 199, pp. 426-428

  6. Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome

    American Journal of Cardiology, Vol. 115, Núm. 5, pp. 587-591

  7. Review of obesity and atrial fibrillation: Exploring the paradox

    Journal of Atrial Fibrillation, Vol. 8, Núm. 2, pp. 21-25

2014

  1. Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists

    International Journal of Cardiology, Vol. 176, Núm. 3, pp. 1259-1261